COVID-19

{A woman visits the pharmacy at Hopital Methodiste in Dabou, Cote D'Ivoire. Photo Credit: Fabrice Duhal}A woman visits the pharmacy at Hopital Methodiste in Dabou, Cote D'Ivoire. Photo Credit: Fabrice Duhal

To read this article in French, please click here.

Antimicrobial resistance (AMR) is a major threat in Côte d’Ivoire and requires rapid measures to contain it.

For example, the average resistance to amoxicillin rose from 73.7% in 2012 to 87.3% in 2017 (Report of the Observatoire des résistances des microorganismes aux antiinfectieux en Côte d’Ivoire (Observatory on the resistance of microorganisms to anti-infectives in Côte d’Ivoire) for 2017). This shows that resistance to this commonly used antibiotic is very high and rising in the country.

However, in recent years and following the World Health Organization (WHO) Joint External Evaluation in the country in 2016, Côte d’Ivoire has forged ahead with strategic measures to advance its fight against AMR.

{Photo credit: Samy Rakotoniaina/MSH}Photo credit: Samy Rakotoniaina/MSH

Originally published in The Hill 

By Marian W. Wentworth and Wade Warren 

On Dec. 14, the United States crossed a grisly milestone of 300,000 lives lost to the coronavirus pandemic. That same week, we saw the first glimmer of light in this long, dark tunnel of a year as frontline health care workers began to receive an effective vaccine. 

Subscribe to RSS - COVID-19